Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML). Jetani H, Navarro-Bailon A, Maucher M, Frenz S, et al. Blood 2021 Jul 21. pii: 476427. doi: 10.1182/blood.2020009192.

Read + Share

Amedeo Smart

Independent Medical Education

Jetani H, Navarro-Bailon A, Maucher M, Frenz S, et al. Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML). Blood 2021 Jul 21. pii: 476427. doi: 10.1182/blood.2020009192.
PMID: 34289026